The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Xenon Pharmaceuticals Inc shares valued at $91 were sold by GANNON STEVEN on Jun 05 ’25. At $30.48 per share, GANNON STEVEN sold 3 shares. The insider’s holdings dropped to 7,141 shares worth approximately $0.23 million following the completion of this transaction.
Also, MORTIMER IAN sold 22,468 shares, netting a total of over 903,214 in proceeds. Following the sale of shares at $40.20 each, the insider now holds 31,302 shares.
Before that, MORTIMER IAN had sold 16,315 shares from its account. In a trade valued at $660,806, the PRESIDENT & CEO traded Xenon Pharmaceuticals Inc shares for $40.50 each. Upon closing the transaction, the insider’s holdings decreased to 16,315 shares, worth approximately $1.01 million.
As published in their initiating research note from Chardan Capital Markets on May 07, 2025, Xenon Pharmaceuticals Inc [XENE] has been a Buy and the price target has been revised to $55. Analysts at Deutsche Bank started covering the stock with ‘”a Buy”‘ outlook in a report released in mid February. Earlier on October 01, 2024, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for XENE stock.
Analyzing XENE Stock Performance
On last trading session,, Xenon Pharmaceuticals Inc [NASDAQ: XENE] rose 1.39% to $32.2. The stock’s lowest price that day was $31.45, but it reached a high of $32.23 in the same session. During the last five days, there has been a surge of approximately 0.94%. Over the course of the year, Xenon Pharmaceuticals Inc shares have dropped approximately -13.93%. Shares of the company reached a 52-week high of $42.23 on 01/02/25 and a 52-week low of $26.74 on 04/09/25.
Support And Resistance Levels for Xenon Pharmaceuticals Inc (XENE)
According to the 24-hour chart, there is a support level at 31.62, which, if violated, would cause prices to drop to 31.03. In the upper region, resistance lies at 32.51. The next price resistance is at 32.81. RSI (Relative Strength Index) is 52.33 on the 14-day chart, showing neutral technical sentiment.
Is Xenon Pharmaceuticals Inc subject to short interest?
Stocks of Xenon Pharmaceuticals Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.22 million shares to 3.69 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.47 million shares. A jump of 5.98% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.87 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.87.
Which companies own the most shares of Xenon Pharmaceuticals Inc (XENE)?
In terms of Xenon Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 42 in the next 12 months, up nearly 32.24% from the previous closing price of $31.76. Analysts anticipate Xenon Pharmaceuticals Inc stock to reach 42 by 2025, with the lowest price target being 42. In spite of this, 10 analysts ranked Xenon Pharmaceuticals Inc stock as Buy at the end of 2025. On January 04, 2024, Citigroup assigned a price target of “a Buy” to the stock and initiated coverage with a $62.
